NasdaqGM - Nasdaq Real Time Price USD

Entrada Therapeutics, Inc. (TRDA)

8.24
+0.23
+(2.87%)
At close: 4:00:00 PM EDT
8.24
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
172,220
210,782
129,013
0
0
Operating Expense
168,112
163,771
132,175
97,248
51,127
Operating Income
4,108
47,011
-3,162
-97,248
-51,127
Net Non Operating Interest Income Expense
19,701
19,474
15,218
2,632
-31
Pretax Income
23,809
66,485
12,056
-94,616
-51,158
Tax Provision
-972
859
18,741
0
--
Net Income Common Stockholders
24,781
65,626
-6,685
-94,616
-51,158
Diluted NI Available to Com Stockholders
24,781
65,626
-6,685
-94,616
-51,158
Basic EPS
0.64
--
-0.20
-3.02
-8.16
Diluted EPS
0.58
--
-0.20
-3.02
-8.16
Basic Average Shares
39,200.53
--
33,050.32
31,293.31
6,267.78
Diluted Average Shares
40,573.87
--
33,050.32
31,293.31
6,267.78
Total Operating Income as Reported
4,108
47,011
-3,162
-97,248
-51,127
Total Expenses
168,112
163,771
132,175
97,248
51,127
Net Income from Continuing & Discontinued Operation
24,781
65,626
-6,685
-94,616
-51,158
Normalized Income
24,781
65,626
-6,685
-94,616
-51,158
Interest Income
19,701
19,474
15,218
2,632
--
Net Interest Income
19,701
19,474
15,218
2,632
-31
EBIT
4,108
47,011
-3,162
-97,248
-51,127
EBITDA
7,893
50,784
-321
-95,353
-50,010
Reconciled Depreciation
3,785
3,773
2,841
1,895
1,117
Net Income from Continuing Operation Net Minority Interest
24,781
65,626
-6,685
-94,616
-51,158
Normalized EBITDA
7,893
50,784
-321
-95,353
-50,010
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TCRX TScan Therapeutics, Inc.
1.2100
-2.42%
 
PEPG PepGen Inc.
1.5800
+6.04%
 
KRRO Korro Bio, Inc.
16.18
+2.99%
 
HOOK HOOKIPA Pharma Inc.
1.7450
+14.80%
 
NRIX Nurix Therapeutics, Inc.
10.14
+6.62%
 
RNA Avidity Biosciences, Inc.
31.64
+4.70%
 
KOD Kodiak Sciences Inc.
4.0600
+9.43%
 
TYRA Tyra Biosciences, Inc.
9.98
+3.10%
 
PBYI Puma Biotechnology, Inc.
3.6300
+1.40%
 
ELVN Enliven Therapeutics, Inc.
17.38
+3.15%